Page last updated: 2024-08-22

tranylcypromine and Alzheimer Disease

tranylcypromine has been researched along with Alzheimer Disease in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19903 (60.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (20.00)24.3611
2020's1 (20.00)2.80

Authors

AuthorsStudies
Han, KM; Hoe, HS; Jeon, H; Jeon, SG; Jeong, YH; Kim, YG; Lee, H; Lee, JS; Lee, YH; Lin, Y; Park, H; Park, JH1
Belakavadi, M; Dell, J; Fondell, JD; Grover, GJ1
Eisenhofer, G; Goldstein, DS; Keiser, HR; Kopin, IJ; Murphy, DL; Stull, R; Sunderland, T1
Cohen, RM; Mueller, EA; Murphy, DL; Newhouse, PA; Sunderland, T; Tariot, PN1
Jenike, MA1

Trials

1 trial(s) available for tranylcypromine and Alzheimer Disease

ArticleYear
Tranylcypromine compared with L-deprenyl in Alzheimer's disease.
    Journal of clinical psychopharmacology, 1988, Volume: 8, Issue:1

    Topics: Aged; Alzheimer Disease; Female; Humans; Male; Middle Aged; Phenethylamines; Psychiatric Status Rating Scales; Selegiline; Tranylcypromine

1988

Other Studies

4 other study(ies) available for tranylcypromine and Alzheimer Disease

ArticleYear
The MAO Inhibitor Tranylcypromine Alters LPS- and Aβ-Mediated Neuroinflammatory Responses in Wild-type Mice and a Mouse Model of AD.
    Cells, 2020, 08-28, Volume: 9, Issue:9

    Topics: Alzheimer Disease; Animals; Disease Models, Animal; Humans; Inflammation; Lipopolysaccharides; Mice; Monoamine Oxidase Inhibitors; Tranylcypromine

2020
Thyroid hormone suppression of β-amyloid precursor protein gene expression in the brain involves multiple epigenetic regulatory events.
    Molecular and cellular endocrinology, 2011, Jun-06, Volume: 339, Issue:1-2

    Topics: Acetylation; Alzheimer Disease; Amyloid beta-Protein Precursor; Animals; Brain; Cell Line, Tumor; Epigenesis, Genetic; Gene Expression Regulation; Histone Deacetylase Inhibitors; Histone Demethylases; Histones; Humans; Hydroxamic Acids; Male; Methylation; Promoter Regions, Genetic; Protein Processing, Post-Translational; Rats; Rats, Sprague-Dawley; Receptors, Thyroid Hormone; Tranylcypromine; Triiodothyronine

2011
Simultaneous liquid-chromatographic determination of 3,4-dihydroxyphenylglycol, catecholamines, and 3,4-dihydroxyphenylalanine in plasma, and their responses to inhibition of monoamine oxidase.
    Clinical chemistry, 1986, Volume: 32, Issue:11

    Topics: Alzheimer Disease; Animals; Catecholamines; Chromatography, Liquid; Depression; Dihydroxyphenylalanine; Dogs; Glycols; Humans; Methoxyhydroxyphenylglycol; Monoamine Oxidase Inhibitors; Posture; Quality Control; Selegiline; Tranylcypromine

1986
Monoamine oxidase inhibitors as treatment for depressed patients with primary degenerative dementia (Alzheimer's disease).
    The American journal of psychiatry, 1985, Volume: 142, Issue:6

    Topics: Age Factors; Aged; Alzheimer Disease; Depressive Disorder; Female; Humans; Male; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Tranylcypromine

1985